Shortlist by what you need
Start here if you know why you are leaving JADBio.
Want the closest match?
BioptimusMost similar to JADBio in what it does, its category and its price.
Visit (opens Bioptimus in a new tab)Want the best rated?
Tempus AIRated 4.3 out of 5 in our review, against 3.9 for JADBio.
Visit (opens Tempus AI in a new tab)
At a glance
Green means better than JADBio, red means worse. Prices are starting prices per month.
| Tool | Our rating | Starts at | Free plan | Best for | Compare |
|---|---|---|---|---|---|
 JADBioBaseline | 3.9 | Free | Yes | AutoML built specifically for biological and molecular data, aimed at biomarker discovery by researchers rather than data scientists. | |
| Bioptimus | 4.2+0.3 | Not listed | No | Foundation models for biology spanning molecular, cellular and tissue scales | vs JADBio |
 Paige | 4.1+0.2 | Not listed | No | Digital pathology AI co-pilot from Memorial Sloan Kettering researchers, acquired by Tempus in 2025 | vs JADBio |
 Zephyr AI | 4.0+0.1 | Not listed | No | Precision medicine from real-world data, with interpretable models and no new assays. | vs JADBio |
 QuantHealth | 4.1+0.2 | Not listed | No | Clinical trial simulation platform for predicting patient response to therapies | vs JADBio |
 Qureight | 4.1+0.2 | Not listed | No | Imaging biomarkers for lung and heart clinical trials, from a Cambridge deep-learning lab. | vs JADBio |
 Aizon | 4.0+0.1 | Not listed | No | An AI platform for pharmaceutical manufacturers that catches quality deviations in GxP-regulated production data. | vs JADBio |
 Immunai | 4.0+0.1 | Not listed | No | AI platform mapping the human immune system at single-cell resolution to accelerate drug discovery for pharma partners. | vs JADBio |
| Tempus AI | 4.3+0.4 | Not listed | No | Publicly traded on Nasdaq, guiding to $1.6 billion in 2026 revenue | vs JADBio |
The alternatives in detail
In order of how closely each one matches JADBio.
Bioptimus
4.2Not listed
vs JADBio+0.3
Foundation models for biology spanning molecular, cellular and tissue scales.
- Foundation models trained across molecular, cellular and tissue scales
- Digital pathology models for research and trial workflows
- Transfer learning that reuses existing imaging and omics archives
Cross-scale model design rather than one narrow task classifier
Requires in-house validation on local cohorts before clinical reliance
Paige
4.1Not listed
vs JADBio+0.2
Digital pathology AI co-pilot from Memorial Sloan Kettering researchers, acquired by Tempus in 2025.
- Paige Alba AI co-pilot for digital pathology tissue-slide analysis
- Cancer diagnosis, tissue subtyping, and molecular biomarker discovery support
- Founded in 2017 by researchers from Memorial Sloan Kettering Cancer Center
Research pedigree from Memorial Sloan Kettering lends real clinical credibility
Enterprise-only pricing requires a sales conversation before evaluation
Zephyr AI
4.0Not listed
vs JADBio+0.1
Precision medicine from real-world data, with interpretable models and no new assays.
- Multi-modal real-world data integration
- Interpretable machine learning models
- Discovery, validation and deployment coverage
Interpretable models, which is what makes a target hypothesis actionable
No published pricing, contact only
QuantHealth
4.1Not listed
vs JADBio+0.2
Clinical trial simulation platform for predicting patient response to therapies.
- In-silico simulation of clinical trial outcomes
- Patient response prediction across therapy candidates
- Protocol testing before a trial is committed
Tests expensive protocol decisions before commitment
Credibility depends on retrospective validation in the same indication
Qureight
4.1Not listed
vs JADBio+0.2
Imaging biomarkers for lung and heart clinical trials, from a Cambridge deep-learning lab.
- Deep-learning lung imaging biomarkers Lung8, Air8 and Fibr8
- Glass8 and Vascul8 for vascular and parenchymal measures
- Central reads and endpoint discovery for trials
Consistent measurement reduces the variability that costs trial power
No published pricing; sold to trial sponsors
Aizon
4.0Not listed
vs JADBio+0.1
An AI platform for pharmaceutical manufacturers that catches quality deviations in GxP-regulated production data.
- Real-time deviation detection across GxP manufacturing data
- Audit-ready documentation generated automatically from production data
- Aizon Predict available as an AWS Marketplace private offer
Deep specialization in GxP compliance sets it apart from general manufacturing-analytics tools
Pricing is entirely custom and not disclosed anywhere publicly
Immunai
4.0Not listed
vs JADBio+0.1
AI platform mapping the human immune system at single-cell resolution to accelerate drug discovery for pharma partners.
- AMICA-OS platform built on single-cell multi-omic immune system data
- Target discovery tools for identifying new drug candidates from immune cell behavior
- Preclinical evaluation modeling for testing target hypotheses before trials
Dataset scale, built through partnerships with Fortune 100 pharma companies, gives its models depth smaller labs can't replicate
No published pricing; every engagement is a custom partnership negotiation
Tempus AI
4.3Not listed
vs JADBio+0.4
Publicly traded on Nasdaq, guiding to $1.6 billion in 2026 revenue.
- Machine learning applied to genomic and clinical data for precision treatment matching
- One of the largest connected libraries of clinical and molecular data
- Publicly traded on Nasdaq under the ticker TEM
Publicly reported financials give unusual transparency into scale and growth
Pricing runs through insurance billing and enterprise agreements, not published rates
FAQ
Questions people ask
Is JADBio free?
JADBio has a free plan.
How did you pick these alternatives?
We match tools on what they do, their category and their price, using the details in our directory. Ratings come from our reviews and reader reviews.